Thursday, February 27, 2020

Financial News Conference Full Year 2019 Results

Location: Leverkusen, Baykomm (Bayer‘s Communication Center)

 

Bayer strategically and operationally successful

  • Group sales advance by 3.5 percent (Fx & portfolio adj.) to 43.545 billion euros
  • EBITDA before special items increases by 28.3 percent to 11.503 billion euros
  • Core earnings per share up by 14.3 percent to 6.40 euros
  • Net income rises 141.4 percent to 4.091 billion euros – gain of 1.637 billion euros on sale of Currenta stake
  • Free cash flow of 4.214 billion euros above expectations
  • Proposed dividend of 2.80 euros per share
  • Crop Science shows solid performance in challenging environment, substantial increase in earnings due to acquired business
  • Pharmaceuticals shows encouraging business development
  • Sales growth at Consumer Health, earnings at prior-year level despite divestments
  • Ongoing portfolio, structural and efficiency measures implemented successfully
  • Glyphosate’s positive safety profile confirmed – appeal and mediation proceedings moving forward
  • Outlook for 2020: increase in sales, earnings and free cash flow
  • Ambitious sustainability targets set

    MORE

 

Links

Annual Report 2019

 

Recording of the Conference

Audio: MP3 for download (48.80 MB, 106:36 min.) (dubbed into English)

Video: Webcast with slides

 

Speaker

Follow us:

 

Twitter Logo   You will find the key statements on Twitter